|
English
|
正體中文
|
简体中文
|
总笔数 :0
|
|
造访人次 :
53338487
在线人数 :
598
教育部委托研究计画 计画执行:国立台湾大学图书馆
|
|
|
显示项目 273651-273660 / 2348964 (共234897页)
<< < 27361 27362 27363 27364 27365 27366 27367 27368 27369 27370 > >>
每页显示[10|25|50]项目
| 高雄醫學大學 |
2006 |
Comparison of Gd-Bz-TTDA, Gd-EOB-DTPA and Gd-BOPTA in dynamic MR imaging of the liver with rat model
|
趙垂勳;劉金昌;王雲銘;陳世賢;許瑞昇;許鳳娥 |
| 國立交通大學 |
2014-12-08T15:22:53Z |
Comparison of Gd-Bz-TTDA, Gd-EOB-DTPA, and Gd-BOPTA for dynamic MR imaging of the liver in rat models
|
Jaw, Twei-Shiun; Chen, Shih-Hsien; Wang, Yun-Ming; Hsu, Jui-Sheng; Kuo, Yu-Ting; Chiu, Yen-Yu; Tsai, Kun-Bow; Hsieh, Tsyh-Jyi; Liu, Gin-Chung |
| 中國醫藥大學 |
2002-03-16 |
Comparison of Gd（DTPA-BBA）and Ferumoxide for Detection of Small Hepatomas
|
陳中和(Chen,Jeon-Hor) |
| 國立臺灣大學 |
2013 |
Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancer
|
Shao, Yu-Yun; Shau, Wen-Yi; Lin, Zhong-Zhe; Chen, Ho-Min; Kuo, Raymond; Yang, James Chih-Hsin; Lai, Mei-Shu; 楊志新; 邵幼雲; 賴美淑; 林宗哲 |
| 臺大學術典藏 |
2020-04-10T12:16:09Z |
Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancer
|
YU-YUN SHAO; Shau W.-Y.; Lin Z.-Z.; Chen H.-M.; Kuo R.; Yang J.C.-H.; Lai M.-S. |
| 臺大學術典藏 |
2020-05-26T09:27:04Z |
Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancer
|
Shao Y.-Y;Shau W.-Y;Lin Z.-Z;Chen H.-M;Kuo R;Chih-Hsin Yang;Lai M.-S.; Shao Y.-Y; Shau W.-Y; Lin Z.-Z; Chen H.-M; Kuo R; CHIH-HSIN YANG; Lai M.-S. |
| 臺大學術典藏 |
2021-08-11T03:46:44Z |
Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancer
|
Shao Y.-Y.; Shau W.-Y.; ZHONG-ZHE LIN; Chen H.-M.; Kuo R.; Yang J.C.-H.; Lai M.-S. |
| 臺大學術典藏 |
2022-06-10T06:11:07Z |
Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancer
|
Shao Y.-Y.; Shau W.-Y.; ZHONG-ZHE LIN; Chen H.-M.; Kuo R.; Yang J.C.-H.; Lai M.-S. |
| 臺大學術典藏 |
2018-09-10T08:29:55Z |
Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations
|
Wu, J.-Y. and Wu, S.-G. and Yang, C.-H. and Chang, Y.-L. and Chang, Y.-C. and Hsu, Y.-C. and Shih, J.-Y. and Yang, P.-C.; YIH-LEONG CHANG; YEUN-CHUNG CHANG; JIN-YUAN SHIH |
| 臺大學術典藏 |
2011 |
Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations
|
Yang C.-H.; YIH-LEONG CHANG; Chang Y.-C.; Hsu Y.-C.; Shih J.-Y.; Yang P.-C.; Wu S.-G.; Wu J.-Y. |
显示项目 273651-273660 / 2348964 (共234897页)
<< < 27361 27362 27363 27364 27365 27366 27367 27368 27369 27370 > >>
每页显示[10|25|50]项目
|
